Dynamics of HIV-1 recombination in its natural target cells
AUTOR(ES)
Levy, David N.
FONTE
National Academy of Sciences
RESUMO
Genetic recombination is believed to assist HIV-1 diversification and escape from host immunity and antiviral therapies, yet this process remains largely unexamined within the natural target-cell populations. We developed a method for measuring HIV-1 recombination directly that employs reporter viruses bearing functional enhanced yellow fluorescent protein (YFP) and enhanced cyan fluorescent protein (CFP) genes in which recombination produces a modified GFP gene and GFP fluorescence in the infected cells. These reporter viruses allow simultaneous quantification of the dynamics of HIV-1 infection, coinfection, and recombination in cell culture and in animal models by flow-cytometric analysis. Multiround infection assays revealed that productive cellular coinfection was subject to little functional inhibition. As a result, generation of recombinants proceeded according to the square of the infection rate during HIV-1 replication in T lymphocytes and within human thymic grafts in severe combined immunodeficient (SCID)-hu (Thy/Liv) mice. These results suggest that increases in viral load may confer a compounding risk of virus escape by means of recombinational diversification. A single round of replication in T lymphocytes in culture generated an average of nine recombination events per virus, and infection of macrophages led to ≈30 crossover events, making HIV-1 up to an order of magnitude more recombinogenic than recognized previously and demonstrating that the infected cell exerts a profound influence on the frequency of recombination.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=384719Documentos Relacionados
- Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.
- Molecular dynamics studies of the HIV-1 TAR and its complex with argininamide
- Antiretroviral monotherapies and serum HIV-1 dynamics.
- Persistent HIV-1 infection of natural killer cells in patients receiving highly active antiretroviral therapy
- Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo.